Autism and Type 2 diabetes

Summary:

Type 2 diabetes is found among people with Autism, especially for people who are male, 30-39 old.

The study analyzes which people have Type 2 diabetes with Autism. It is created by eHealthMe based on reports of 14 people who have Autism from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Autism?

Autism (a mental condition, present from early childhood, characterized by difficulty in communicating and forming relationships with other people and in using language and abstract concepts) is found to be associated with 105 drugs and 283 conditions by eHealthMe. Check the latest studies of Autism.

What is Type 2 diabetes?

Type 2 diabetes is found to be associated with 1,433 drugs and 2,345 conditions by eHealthMe. Check the latest studies of Type 2 diabetes.



On Jul, 16, 2026

14 people who have Autism and Type 2 Diabetes are studied.

Would you have Type 2 diabetes when you have Autism?

Gender of people who have Autism and experienced Type 2 Diabetes *:

  • female: 7.14 %
  • male: 92.86 %

Age of people who have Autism and experienced Type 2 Diabetes *:

  • 0-1: 0.0 %
  • 2-9: 16.67 %
  • 10-19: 33.33 %
  • 20-29: 0.0 %
  • 30-39: 41.67 %
  • 40-49: 8.33 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 28.57%
  2. High Blood Cholesterol: 4 people, 28.57%
  3. Diabetic Nephropathy (diabetic kidney disease): 4 people, 28.57%
  4. Affective Disorder (mental disorder): 4 people, 28.57%
  5. Sleep Disorder: 3 people, 21.43%
  6. Oppositional Defiant Disorder (a childhood disorder described by the diagnostic and statistical manual of mental disorders): 2 people, 14.29%
  7. Mania (a state of abnormally elevated or irritable mood): 1 person, 7.14%
  8. Learning Disability (difficulty in learning): 1 person, 7.14%
  9. Impulse-Control Disorder: 1 person, 7.14%
  10. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 7.14%

Common drugs taken by these people *:

  1. Seroquel: 11 people, 78.57%
  2. Risperdal: 9 people, 64.29%
  3. Abilify: 8 people, 57.14%
  4. Benztropine Mesylate: 5 people, 35.71%
  5. Clonazepam: 5 people, 35.71%
  6. Phenytoin Sodium: 5 people, 35.71%
  7. Lorazepam: 5 people, 35.71%
  8. Lipitor: 4 people, 28.57%
  9. Lithium Carbonate: 3 people, 21.43%
  10. Clarinex: 2 people, 14.29%

Common symptoms for these people *:

  1. Weight Loss: 9 people, 64.29%
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 5 people, 35.71%
  3. High Blood Cholesterol: 5 people, 35.71%
  4. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 28.57%
  5. Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 4 people, 28.57%
  6. Dyslipidaemia (abnormal amount of lipids): 4 people, 28.57%
  7. Weight Increased: 3 people, 21.43%
  8. Gynecomastia (enlargement of the gland tissue of the male breast): 3 people, 21.43%
  9. Dyspnea (difficult or laboured breathing): 2 people, 14.29%
  10. Diabetes: 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Type 2 diabetes?

- Check whether Type 2 diabetes is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Type 2 diabetes:

All the conditions that are associated with Type 2 diabetes:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Type 2 diabetes and Autism, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: